These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16638197)

  • 1. [Expression of SDF-1 gene in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome].
    Zhang YZ; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):281-4. PubMed ID: 16638197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
    Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change of cytokine expressions on bone marrow mesenchymal stem cells in patients with bone marrow failure syndromes and its significance].
    Yang SM; Lu SF; Fei XM; Zhang JF; Shen WY; Li JY; Lu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1560-3. PubMed ID: 21176370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes.
    Xiong H; Yang XY; Han J; Wang Q; Zou ZL
    Braz J Med Biol Res; 2015 Mar; 48(3):207-13. PubMed ID: 25608238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
    Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
    Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].
    Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang Z; Zhang X; Wu LY; Li X; Chang CK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):127-32. PubMed ID: 23611219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro biological characteristics of mesenchymal stem cells from patients with myelodysplastic syndrome and their support to hematopoiesis].
    Zhang YZ; Da WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):839-42. PubMed ID: 16277854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
    Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
    Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of stromal cell derived factor-1 with angiogenesis and cell apoptosis in myelodysplastic syndromes].
    Zhi YQ; Zhang YZ; Zhao HF; Zhao DD; Xia B; Wu XX; Da WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1438-42. PubMed ID: 22169299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
    Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
    Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
    Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
    Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro.
    Calkoen FG; Vervat C; van Pel M; de Haas V; Vijfhuizen LS; Eising E; Kroes WG; 't Hoen PA; van den Heuvel-Eibrink MM; Egeler RM; van Tol MJ; Ball LM
    Stem Cell Res; 2015 Mar; 14(2):198-210. PubMed ID: 25679997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of a mouse pDsRed2-N1-SDF-1alpha eukaryotic expression vector and its expression in mouse bone marrow mesenchymal stem cells].
    Li M; Zhang SZ; Zou ZH; Guo YW; Lu FF; Jiang XD; Kou SB; Lu GH; Li ZY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):439-42. PubMed ID: 20335104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.
    Liang X; Su YP; Kong PY; Zeng DF; Chen XH; Peng XG; Zou ZM; Xu H
    Int J Radiat Biol; 2010 Mar; 86(3):230-7. PubMed ID: 20201651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotaxis-related factors are expressed abnormally in bone marrow mesenchymal stem cells of multiple myeloma patients].
    Hu HJ; Lu H; Fei XM; Li JX; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):59-63. PubMed ID: 21362222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.
    Fei CM; Guo J; Zhao YS; Zhao SD; Zhen QQ; Shi L; Li X; Chang CK
    J Transl Med; 2018 Aug; 16(1):234. PubMed ID: 30143008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
    Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
    Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow mesenchymal stem cells derived from patients with myelodysplastic syndrome possess immunosuppressive activity].
    Zhang YZ; DA WM; Huang WR; Gao CJ; Guo B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):302-5. PubMed ID: 17493336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.